Laura Davison

454 total citations
21 papers, 179 citations indexed

About

Laura Davison is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Laura Davison has authored 21 papers receiving a total of 179 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 9 papers in Oncology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Laura Davison's work include CAR-T cell therapy research (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Immune Cell Function and Interaction (4 papers). Laura Davison is often cited by papers focused on CAR-T cell therapy research (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Immune Cell Function and Interaction (4 papers). Laura Davison collaborates with scholars based in United States, Canada and India. Laura Davison's co-authors include Trine N. Jørgensen, Wim van Schooten, Ute Schellenberger, Kevin Dang, Duy Pham, Linda K. Weiss, Mary K. O'Keeffe, Nathan D. Trinklein, Udaya S. Rangaswamy and Andrew Baum and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Frontiers in Immunology.

In The Last Decade

Laura Davison

20 papers receiving 176 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Davison United States 9 90 63 48 35 33 21 179
A Orfao Spain 6 97 1.1× 40 0.6× 17 0.4× 58 1.7× 28 0.8× 7 239
Martyn Ronald Schaafsma Netherlands 6 48 0.5× 55 0.9× 5 0.1× 62 1.8× 7 0.2× 11 176
Kevin Dang United States 6 62 0.7× 131 2.1× 113 2.4× 36 1.0× 14 174
Hayley A. Hanby United States 5 42 0.5× 12 0.2× 13 0.3× 41 1.2× 5 0.2× 11 145
Nancy Moore United States 6 12 0.1× 40 0.6× 9 0.2× 47 1.3× 9 0.3× 13 128
Rita Frangiamore Italy 11 22 0.2× 12 0.2× 14 0.3× 38 1.1× 25 0.8× 24 291
Heather C. Murray Australia 7 34 0.4× 33 0.5× 6 0.1× 99 2.8× 7 0.2× 17 210
Abigail E. Case United States 6 26 0.3× 23 0.4× 7 0.1× 62 1.8× 6 0.2× 8 232
Thomas Balligand Belgium 6 19 0.2× 17 0.3× 11 0.2× 70 2.0× 22 0.7× 12 146
Verena Kalter Germany 6 80 0.9× 39 0.6× 8 0.2× 44 1.3× 1 0.0× 8 148

Countries citing papers authored by Laura Davison

Since Specialization
Citations

This map shows the geographic impact of Laura Davison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Davison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Davison more than expected).

Fields of papers citing papers by Laura Davison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Davison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Davison. The network helps show where Laura Davison may publish in the future.

Co-authorship network of co-authors of Laura Davison

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Davison. A scholar is included among the top collaborators of Laura Davison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Davison. Laura Davison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manley, Thomas, Starlynn Clarke, Manpreet Kaur, et al.. (2025). A novel CD28 x Nectin-4 costimulatory bispecific antibody for advanced bladder cancer.. Journal of Clinical Oncology. 43(5_suppl). 810–810. 1 indexed citations
2.
Kaur, Manpreet, Udaya S. Rangaswamy, Laura Davison, et al.. (2025). Potency-optimized CD28-activating bispecific antibody for the targeted treatment of Nectin-4 positive cancers. Journal for ImmunoTherapy of Cancer. 13(4). e011323–e011323.
3.
Dang, Kevin, Laure‐Hélène Ouisse, Benjamin Buelow, et al.. (2022). TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity. mAbs. 14(1). 2095949–2095949. 19 indexed citations
4.
5.
Davison, Laura, et al.. (2021). S100a9 Protects Male Lupus-Prone NZBWF1 Mice From Disease Development. Frontiers in Immunology. 12. 681503–681503. 10 indexed citations
6.
Boudreau, Andrew, Benjamin Buelow, Kevin Dang, et al.. (2021). TNB-486 induces potent tumor cell cytotoxicity coupled with low cytokine release in preclinical models of B-NHL. mAbs. 13(1). 1890411–1890411. 22 indexed citations
7.
Buelow, Ben, Kevin Dang, Pranjali Dalvi, et al.. (2020). Effect of modulation of CD3 binding in a PSMAxCD3 T-cell engaging bispecific antibody on maintenance of efficient tumor cell kill and cytokine release.. Journal of Clinical Oncology. 38(15_suppl). e17583–e17583. 1 indexed citations
8.
Buelow, Ben, Andrew Boudreau, Laura Davison, et al.. (2020). A CD3 x FRα T-cell engaging bispecific antibody for efficient killing of ovarian cancer cells with minimal cytokine release.. Journal of Clinical Oncology. 38(15_suppl). e18050–e18050. 1 indexed citations
9.
Davison, Laura, Jessie Liu, Lei Huang, et al.. (2019). Limited Effect of Indolamine 2,3-Dioxygenase Expression and Enzymatic Activity on Lupus-Like Disease in B6.Nba2 Mice. Frontiers in Immunology. 10. 2017–2017. 9 indexed citations
10.
Buelow, Ben, Udaya S. Rangaswamy, Andrew Boudreau, et al.. (2019). TNB-486, a Novel Fully Human Bispecific CD19 x CD3 Antibody That Kills CD19-Positive Tumor Cells with Minimal Cytokine Secretion. Blood. 134(Supplement_1). 4070–4070. 6 indexed citations
11.
Clarke, Starlynn, Kevin Dang, Yuping Li, et al.. (2019). A novel CD3xPSMA bispecific antibody for efficient T cell mediated killing of prostate tumor cells with minimal cytokine release.. Journal of Clinical Oncology. 37(7_suppl). 324–324. 2 indexed citations
12.
Buelow, Ben, Starlynn Clarke, Kevin Dang, et al.. (2018). Pre-clinical development of TNB-383B, a fully human T-cell engaging bispecific antibody targeting BCMA for the treatment of multiple myeloma.. Journal of Clinical Oncology. 36(15_suppl). 8034–8034. 19 indexed citations
13.
Rangaswamy, Udaya S., Andrew Boudreau, Ben Buelow, et al.. (2018). A novel T-cell bispecific antibody platform for efficient T-cell mediated killing of tumor cells with minimal cytokine release.. Journal of Clinical Oncology. 36(5_suppl). 209–209. 4 indexed citations
14.
Aldred, Shelley Force, Andrew Boudreau, Ben Buelow, et al.. (2018). Multispecific antibodies targeting CD38 show potent tumor-specific cytotoxicity.. Journal of Clinical Oncology. 36(5_suppl). 57–57. 2 indexed citations
15.
Buelow, Ben, Priya Choudhry, Starlynn Clarke, et al.. (2018). Development of a fully human t-cell engaging bispecific antibody for the treatment of multiple myeloma.. Journal of Clinical Oncology. 36(5_suppl). 60–60. 5 indexed citations
16.
Davison, Laura & Trine N. Jørgensen. (2017). New Treatments for Systemic Lupus Erythematosus on the Horizon: Targeting Plasmacytoid Dendritic Cells to Inhibit Cytokine Production. Journal of Clinical & Cellular Immunology. 8(6). 11 indexed citations
17.
Davison, Laura & Trine N. Jørgensen. (2014). Sialic Acid–Binding Immunoglobulin‐Type Lectin H–Positive Plasmacytoid Dendritic Cells Drive Spontaneous Lupus‐like Disease Development in B6.Nba2 Mice. Arthritis & Rheumatology. 67(4). 1012–1022. 37 indexed citations
18.
Johnson, Angela, Laura Davison, Natalia V. Giltiay, et al.. (2012). Lack of T cells in Act1‐deficient mice results in elevated IgM‐specific autoantibodies but reduced lupus‐like disease. European Journal of Immunology. 42(7). 1695–1705. 10 indexed citations
19.
Norman, Catalina, Iain B. Lambert, Laura Davison, Douglas W. Bryant, & D. R. McCalla. (1990). Formation and persistence of DNA adducts in rats following intraperitoneal administration of 1,8-dinitropyrene. Carcinogenesis. 11(6). 1037–1040. 3 indexed citations
20.
Norman, Catalina, Iain B. Lambert, Laura Davison, Douglas W. Bryant, & D. R. McCalla. (1989). SHORT COMMUNICATION: DNA adduct formation in primary rabbit tracheal epithelial cells following treatment with 1, 8-dinitropyrene and its partially reduced derivative, 1-nitro-8-nitrosopyrene. Carcinogenesis. 10(7). 1323–1327. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Orfao Breakdown of academic impact, for papers by Martyn Ronald Schaafsma Breakdown of academic impact, for papers by Kevin Dang Breakdown of academic impact, for papers by Hayley A. Hanby Breakdown of academic impact, for papers by Nancy Moore Breakdown of academic impact, for papers by Rita Frangiamore Breakdown of academic impact, for papers by Heather C. Murray Breakdown of academic impact, for papers by Abigail E. Case Breakdown of academic impact, for papers by Thomas Balligand Breakdown of academic impact, for papers by Verena Kalter
Rankless by CCL
2026